Scientists Edit Viable Human Embryos in U.S.

The embryos, whose genes were altered by CRISPR, were not intended for implantation. 

kerry grens
Kerry Grens

Kerry served as The Scientist’s news director until 2021. Before joining The Scientist in 2013, she was a stringer for Reuters Health, the senior health and science reporter at...

View full profile.


Learn about our editorial policies.

Jul 27, 2017

ISTOCK, WILDPIXELFollowing on the achievements of Chinese researchers, scientists in the United States have used CRISPR to manipulate the genomes of viable human embryos, MIT Technology Review reported yesterday (July 26). The work, not yet published, reportedly corrected defective genes from sperm donors in dozens of embryos, which were allowed to grow for several days.

“So far as I know this will be the first study reported in the U.S.,” Jun Wu, a collaborator at the Salk Institute, tells the Review.

See “Human Embryos Genetically Edited Again

The effort was led by Shoukhrat Mitalipov of Oregon Health and Science University. According to the Review, his team applied CRISPR at the point of fertilization, an approach that may reduce off-target effects and ensure all cells in the resulting embryos receive the treatment.

In February, the National Academy of Sciences assembled an international team of ethicists, researchers,...

Interested in reading more?

Scientists Edit Viable Human Embryos in U.S.

The Scientist ARCHIVES

Become a Member of

Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member?